These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 33673112

  • 1. Myocyte Enhancer Factor 2C as a New Player in Human Breast Cancer Brain Metastases.
    Galego S, Kauppila LA, Malhó R, Pimentel J, Brito MA.
    Cells; 2021 Feb 12; 10(2):. PubMed ID: 33673112
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization.
    Sereno M, Haskó J, Molnár K, Medina SJ, Reisz Z, Malhó R, Videira M, Tiszlavicz L, Booth SA, Wilhelm I, Krizbai IA, Brito MA.
    Mol Oncol; 2020 Mar 12; 14(3):520-538. PubMed ID: 31930767
    [Abstract] [Full Text] [Related]

  • 3. Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling.
    Bai XL, Zhang Q, Ye LY, Liang F, Sun X, Chen Y, Hu QD, Fu QH, Su W, Chen Z, Zhuang ZP, Liang TB.
    Oncogene; 2015 Jul 30; 34(31):4089-97. PubMed ID: 25328135
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor-β1 regulates expression of the matrix metalloproteinase 20 (Mmp20) gene through a mechanism involving the transcription factor, myocyte enhancer factor-2C, in ameloblast lineage cells.
    Gao Y, Zhang L, Xiang L, Li B, Liu X, Wang Y, Sun Y.
    Eur J Oral Sci; 2014 Apr 30; 122(2):114-20. PubMed ID: 24495128
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrine phenotypes in a boy with 5q14 deletion syndrome implicate the regulatory roles of myocyte-specific enhancer factor 2C in the postnatal hypothalamus.
    Sakai Y, Ohkubo K, Matsushita Y, Akamine S, Ishizaki Y, Torisu H, Ihara K, Sanefuji M, Kim MS, Lee KU, Shaw CA, Lim J, Nakabeppu Y, Hara T.
    Eur J Med Genet; 2013 Sep 30; 56(9):475-83. PubMed ID: 23832106
    [Abstract] [Full Text] [Related]

  • 6. Myocyte-specific enhancer binding factor 2C expression in human brain development.
    Leifer D, Golden J, Kowall NW.
    Neuroscience; 1994 Dec 30; 63(4):1067-79. PubMed ID: 7700509
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The mammalian target of rapamycin signaling pathway regulates myocyte enhancer factor-2C phosphorylation levels through integrin-linked kinase in goat skeletal muscle satellite cells.
    Wu H, Ren Y, Pan W, Dong Z, Cang M, Liu D.
    Cell Biol Int; 2015 Nov 30; 39(11):1264-73. PubMed ID: 26041412
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phosphorylation-dependent degradation of MEF2C contributes to regulate G2/M transition.
    Badodi S, Baruffaldi F, Ganassi M, Battini R, Molinari S.
    Cell Cycle; 2015 Nov 30; 14(10):1517-28. PubMed ID: 25789873
    [Abstract] [Full Text] [Related]

  • 13. Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer.
    Lee JY, Park K, Lim SH, Kim HS, Yoo KH, Jung KS, Song HN, Hong M, Do IG, Ahn T, Lee SK, Bae SY, Kim SW, Lee JE, Nam SJ, Kim DH, Jung HH, Kim JY, Ahn JS, Im YH, Park YH.
    Oncotarget; 2015 Dec 22; 6(41):43731-42. PubMed ID: 26527317
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comprehensive molecular biomarker identification in breast cancer brain metastases.
    Schulten HJ, Bangash M, Karim S, Dallol A, Hussein D, Merdad A, Al-Thoubaity FK, Al-Maghrabi J, Jamal A, Al-Ghamdi F, Choudhry H, Baeesa SS, Chaudhary AG, Al-Qahtani MH.
    J Transl Med; 2017 Dec 29; 15(1):269. PubMed ID: 29287594
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A, Alhoshani A, Korashy HM.
    Mol Cancer; 2017 Jan 19; 16(1):14. PubMed ID: 28103884
    [Abstract] [Full Text] [Related]

  • 20. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
    Laszlo GS, Alonzo TA, Gudgeon CJ, Harrington KH, Kentsis A, Gerbing RB, Wang YC, Ries RE, Raimondi SC, Hirsch BA, Gamis AS, Meshinchi S, Walter RB.
    J Hematol Oncol; 2015 Oct 20; 8():115. PubMed ID: 26487643
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.